MDT

88.62

+0.16%↑

VEEV

282.49

+2.1%↑

A

120.18

-0.62%↓

WBA

11.53

+0.17%↑

HQY

99.04

-3.72%↓

MDT

88.62

+0.16%↑

VEEV

282.49

+2.1%↑

A

120.18

-0.62%↓

WBA

11.53

+0.17%↑

HQY

99.04

-3.72%↓

MDT

88.62

+0.16%↑

VEEV

282.49

+2.1%↑

A

120.18

-0.62%↓

WBA

11.53

+0.17%↑

HQY

99.04

-3.72%↓

MDT

88.62

+0.16%↑

VEEV

282.49

+2.1%↑

A

120.18

-0.62%↓

WBA

11.53

+0.17%↑

HQY

99.04

-3.72%↓

MDT

88.62

+0.16%↑

VEEV

282.49

+2.1%↑

A

120.18

-0.62%↓

WBA

11.53

+0.17%↑

HQY

99.04

-3.72%↓

Search

Phreesia Inc

Avatud

SektorTervishoid

28.53 0.53

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

28.16

Max

29.04

Põhinäitajad

By Trading Economics

Sissetulek

2.5M

-3.9M

Müük

6.3M

116M

Aktsiakasum

0.226

Kasumimarginaal

-3.376

Töötajad

2,082

EBITDA

2M

4.1M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+11.69% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

3. sept 2025

Turustatistika

By TradingEconomics

Turukapital

294M

1.7B

Eelmine avamishind

28

Eelmine sulgemishind

28.53

Uudiste sentiment

By Acuity

50%

50%

162 / 376 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Neutral Evidence

Phreesia Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. juuli 2025, 19:37 UTC

Suurimad hinnamuutused turgudel
Omandamised, ülevõtmised, äriostud

M3-Brigade Shares Fall on Merger With ReserveOne

8. juuli 2025, 23:45 UTC

Market Talk

Gold Edges Lower, Weighed by Higher Treasury Yields -- Market Talk

8. juuli 2025, 23:42 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

8. juuli 2025, 23:27 UTC

Market Talk

Australian REITs Yet to Offer Enough Appeal -- Market Talk

8. juuli 2025, 23:27 UTC

Market Talk

Global Equities Roundup: Market Talk

8. juuli 2025, 23:21 UTC

Market Talk

Summerset Bull Lauds Strong 2Q Sales Volumes -- Market Talk

8. juuli 2025, 23:21 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. juuli 2025, 22:29 UTC

Omandamised, ülevõtmised, äriostud

Capricorn to Pay A$1.5 Million in Cash and Shares

8. juuli 2025, 22:28 UTC

Omandamised, ülevõtmised, äriostud

Capricorn Metals Enters Binding Agreement to Buy Claw Gold Project

8. juuli 2025, 21:58 UTC

Market Talk

Kura Sushi Closely Watching U.S. Tariff Negotiations on Asian Goods -- Market Talk

8. juuli 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

8. juuli 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

8. juuli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. juuli 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. juuli 2025, 19:53 UTC

Market Talk

Copper Posts Biggest One-Day Gain Ever to Hit Record on Tariff Chatter -- Market Talk

8. juuli 2025, 19:53 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

8. juuli 2025, 19:45 UTC

Market Talk

Canada Unlikely to Succeed in Bid for Tariff-Free Trade With U.S. -- Market Talk

8. juuli 2025, 19:29 UTC

Market Talk

U.S. Consumer-Credit Growth Slowed in May -- Market Talk

8. juuli 2025, 19:20 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

8. juuli 2025, 19:11 UTC

Market Talk

Bank of Canada's Rate Cuts Deliver Muted Relief Along the Curve -- Market Talk

8. juuli 2025, 19:01 UTC

Market Talk

Oil Futures Gain With Support From Products -- Market Talk

8. juuli 2025, 18:49 UTC

Tulu

Hershey Names New CEO, Continuing Leadership Shuffle. The Stock Falls. -- Barrons.com

8. juuli 2025, 18:41 UTC

Market Talk

Mexico's Inflation Seen Mixed in June -- Market Talk

8. juuli 2025, 18:38 UTC

Market Talk

Gold Falls as Markets Digest Details of Trump Tariffs -- Market Talk

8. juuli 2025, 18:23 UTC

Market Talk

Analysts Anticipate Lower Ethanol Inventories -- Market Talk

8. juuli 2025, 18:10 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

8. juuli 2025, 18:10 UTC

Market Talk

Freeport-McMoRan Jumps on Trump Tariff Plan for Copper Imports -- Market Talk

8. juuli 2025, 17:24 UTC

Market Talk

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

8. juuli 2025, 17:06 UTC

Market Talk

KeyCorp and Regional Banks Set for a Catchup -- Market Talk

8. juuli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Phreesia Inc Prognoos

Hinnasiht

By TipRanks

11.69% tõus

12 kuu keskmine prognoos

Keskmine 31.71 USD  11.69%

Kõrge 35 USD

Madal 28 USD

Põhineb 10 Wall Streeti analüütiku instrumendi Phreesia Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

10 ratings

10

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

25.23 / 25.61Toetus ja vastupanu

Lühikene perspektiiv

Neutral Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Bullish Evidence

Sentiment

By Acuity

162 / 376 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.